HLA-class II alleles in Egyptian patients with hepatocellular carcinoma

Immunological Investigations

Volumn 37, Issue 7, 2008, Pages 661-674

  El Chennawi, Farha A ^a   Auf, Fatma A ^a   Metwally, Shereen S ^a   Mosaad, Youssef M ^a   El Wahab, Mohamed A ^a   Tawhid, Ziyad E ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

HCC; HCV; HLA class II alleles; HLA DQB1; HLA DRB1; SSP

Indexed keywords

HLA ANTIGEN CLASS 2;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; EGYPT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ALLELES; CARCINOMA, HEPATOCELLULAR; EGYPT; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 52949118091     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130802111605     Document Type: Article

References (47)

1. Abdel-Wahab, M., Abou El-Enein, A., Abou-Zeid, M., et al. (2000). Hepatocelular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center. J. Hepatol. Gastroenterol. 47:663-668.
2. Acton, R.T. (2001). The major histocompatibility complex. In: Clinical Immunology Principles and Practice. Rich, R.R., Fleisher, T.A., Shearer, W.T. et al. (Eds), Mosby International Ltd., London, 2nd edition, Volume 1, (6):1-13.
3. Aikawa, T., Kojimam, M., Onishi, H., et al. (1996). HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J. Med. Virol. 49(4): 274-278.
4. Alric, L., Fort, M., Izopet, J., et al. (1997). Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 675-1681.
5. Alric, L., Fort, M., Izopet, J., et al. (2000). Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 56: 154-158.
6. Chang, K.M., Rehermann, B., Chisari, F.V. (1997). Immunopathology of hepatitis C. Springer Series, Seminar on Immunopathology 19:57.
7. Cramp, M., Carucci, P., Underhill, J., et al. (1998). Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 29: 207-213.
8. De Re, V., Caggiari, L., Talamini, R., et al. (2004). Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Human Immunol. 65:1397-1404.
9. Donaldson, P.T. (1999). The interrelationship between hepatitis C virus and HLA. Eur. J. Clin. Invest. 29:280-283.
10. Donaldson, P.T., Ho, S., Williams, R., et al. (2001). HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver 21:143-148.
11. El-Borai, M.H., D'alfonso, S., Mazzola, M.E., et al. (1994). A practical approach to HLADR genomic typing by heteroduplex analysis. Human Immunol. 40:41-50.
12. El-Shinnawi, F.A., Djoulah, S., Abbas, F., et al. (1996). HLA class II DRB1 and DQB1 polymorphisms in the Egyptian population of Siwa. Human Immunol. 47:142.
13. El-Zayadi, A., Abaza, H., Shawky, S., et al. (2001). Prevalence and epidemiological features of hepatocellular carcinoma in Egypt - a Single center experience. Hepatol. Res. 19(2):170-179.
14. El-Zayadi, A., Simmonds, P., Dabbous, H., et al. (1996). Response to interferone-α of Egyptian patients infected with hepatitis C virus genotype 4. J. Viral Hepatitis 3:261-264.
15. Fanning, L.J., Levis, J., Kenny-Walsh, E., et al. (2001). HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 33:224-230.
16. Hafez, M., El-Shinnawi, F.A. (1986). HLA-antigens in the Egyptian population. Foren. Sci. Inter. 31:241-246.
17. Hamed, N.A., Hano, A.F., Raouf, H.A., et al. (2005). Relationship between HLA-DR B1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients. Int. J. Cancer 115(2):231-240.
18. Herkel, J., Jagemann, B., Wiegard, C., et al. (2003). MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology 37:1079.
19. Higashi, Y., Kamikawaji, N., Suko, H., Ando, M. (1996). Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C. J. Gastroenterol. Hepatol. 11:241-246.
20. Hue, S., Cacoub, P., Renou, C., et al. (2002). Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis. 1;186(1):106-109.
21. Ince, N., Wands, J.R. (1999). The increasing incidence of hepatocellular carcinoma. N. Engl. J. Med. 340:798-799.
22. Kamel, M.A., Miller, F.D., EL-Masry, A.G. (1994). The epidemiology of schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann. Trop. Med. Parasitol. 88:1-9.
23. Kondo, Y., Kobayashi, K., Kobayashi, T., et al. (2003). Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C. Tohoku J. Exp. Med. 201:109-117.
24. Kuzushita, N., Hayashi, N., Moribe, T., et al. (1998). Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27: 240.
25. Li, P.K., Leung, N.W., Poon, A.S., et al. (1995). Molecular genetics of major histocompatibility complex class II genes in hepatocellular carcinoma. Dig. Dis. Sci. 40(7):1542-1546.
26. Mangia, A., Gentile, R., Cascavilla, I., et al. (1999). HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J. Hepatol. 30: 984-989.
27. McKiernan, S.M., Hagan, R., Curry, M., et al. (2004). Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40:108.
28. Minton, E.J., Smillie, D., Neal, K.R., et al. (1998). Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis. 178:39-44 .
29. Montalto, G., Cervello, M., Giannitrapani, L., et al. (2002). Epidemiology, risk factors and natural history of hepatocellular carcinoma. Ann. NY Acad. Sci. 963:13-20.
30. Nelly, H.M., Heba, M.Z., Nadia, M.M., et al. (2000). Review of epidemiologic and clinicopathologic features of 403 hepatocellular carcinoma patients. J. Egyptian Nat. Cancer Instit. 12(2):87-93.
31. Okuda, K. (2000). Hepatocellular carcinoma. J. Hepatol. 32:225-237.
32. Par, A., Szalay, F., Lakatos, P.L., et al. (2002): Genetic aspects of liver diseases. Orv. Hetil. 6; 143(1):3-12.
33. Parkhill, J., Wren, B.W., Mungall, K., et al. (2000). The genome sequence of the foodborne pathogen campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
34. Pellegris, G., Rovagnani, F., Notti, P., et al. (2002). B and C hepatitis viruses, HLADQ1 and DR3 alleles and autoimmunity in patients with hepatocellular carcinoma. J. Hepatol. 36: 521-526.
35. Rashmi, S., Rashmi, K., Anil, K., Khalid, K. (2007). A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J. Gastroenterol. March 28; 13(12):1770-1787.
36. Shamaa, S., El-Bedeway, A., Aita, M., et al. (2000). Analysis of 192 Egyptian patients with hepatocellular carcinoma. In: Educational Course on Liver Tumors. Omar, S., El-Mawla, N., El-Zawahry, H. (Eds.), European School of Oncology, pp. 86-93.
37. Thio, C.L., Thomas, D.L., Goedert, J.J., et al. (2001). Racial differences in HLA class II associations with hepatitis C virus outcomes. J. Infect. Dis, 1;184(1):16-21.
38. Thursz, M. (2001). MHC and the viral hepatitides. QJM 94:287-291.
39. Thursz, M., Yallop, R., Goldin, R., et al. (1999). Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 354:2119-2124.
40. Tillman, H.L., Chen, D.F., Trautwein, C., et al. (2001). Low frequency of HLA-DRB1* 11 in hepatitis C virus induced end stage liver disease. Gut 48(5): 714-718.
41. Vejbaesya, S., Songsivilai, S., Tanwandee, T., et al. (2000): HLA association with hepatitis C virus infection. Hum. Immunol. 61:348-353.
42. Walker, B.D., Korber, B.T. (2001). Immune control of HIV: the obstacles of HLA and viral diversity. Nat. Immunol. 2: 473.
43. Wawrzynowicz-Syczewska, M., Underhill, J.A., Clare, M.A., et al. (2000). HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 20:234-239.
44. Xin, H., Rong-Bin, Y., Nan-Xiong, S., et al. (2005). Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: A meta-analysis. World J. Gastroenterol. December 14;11(46):7302-7307.
45. Yenigun, A., Durupinar, B. (2002). Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. J. Virol. 76:1787-1789.
46. Zavaglia, C., Martinetti, M., Silini, E., et al. (1998). Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J. Hepatol. 28:1-7.
47. Zekri, A.R., El-Mahallawy, H.A, Hassan, A., et al. (2005):HLA-alleles in Egyptian HCV genotype-4 carriers. Egyptian J. Immunol. 12(1):77-86.